Orticumab featured in Cardiovascular Business post on AI and inflammation. Read the Article.

About Ben Huizinga

This author has not yet filled in any details.
So far Ben Huizinga has created 10 blog entries.

Abcentra Announces Appointment of Dr. Peter Libby as a Board Member as it Enters Orticumab’s Phase 2b Trial (FORTIFY)

LOS ANGELES, June 24, 2025 /PRNewswire/ -- Abcentra LLC (Abcentra), a [...]

By |2025-07-01T00:16:04+00:00July 1, 2025|Press Releases|

American College of Cardiology Presentation Highlights Orticumab’s Promising Results Showing Potential to Reduce Coronary Inflammation

ATLANTA, April 8, 2024 /PRNewswire/ -- Abcentra LLC, a clinical-stage [...]

By |2024-04-08T13:13:14+00:00April 8, 2024|Press Releases|
Go to Top